Drexel University joins leading U.S. children’s hospitals and autism research centres ahead of Q1 2026 510(k) study launch PHILADELPHIA, PA, PA, UNITED STATES ...
With a clear pathway toward FDA submission and strong execution underway, we believe BlinkLab is well positioned to transform how autism is assessed in clinical practice.” — BlinkLab CEO and Managing ...
The commencement of the US pivotal trial is complemented by the recent announcement of a world-first sovereign deployment of Dx1. BlinkLab has entered into a formal agreement with the Foundation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results